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Linker insertion mutants affecting the simian virus 40 (SV40) large tumor (T) antigen were constructed by
inserting a 12-base-pair oligonucleotide linker into restriction endonuclease cleavage sites located within the
early region of SV40. One mutant, with the insertion at amino acid 5, was viable in CV-lp and BSC-1 cells,
indicating that sequences very close to the amino terminus of large T could be altered without affecting the lytic
infection cycle of SV40. All other mutants affecting large T were not viable. In complementation assays between
the linker insertion mutants and either a late-gene mutant, dlBC865, or a host range/helper function (hrlhf)
mutant, dlA2475, delayed complementation was seen with the 6 of the 10 nonviable mutants. Of these 10
mutants, 5 formed plaques 3 to 4 days later than in control complementations, while complementation by one
of the mutants, inA2827, with an insertion at amino acid 520, was delayed more than 1 week. Most mutants
which showed delayed complementation replicated less well in Cos-1 cells than did a control mutant, dlA1209,
which produced no T antigen. The replication of inA2827(aa520) was reduced by more than 90%. Similar
interference with viral DNA replication was seen when CV-1, HeLa, or 293 cells were cotransfected with an
origin-defective plasmid encoding wild-type large T antigen and with inA2827(aaS20). Only one of the mutant
T antigens, inA2807(aa303), was unstable. These results indicate that some of the mutant T antigens interfered
with functions of wild-type T required for viral DNA replication. However, not all of the mutants which showed
delayed complementation also showed interference with viral DNA replication. This indicates that mutant large
T antigens may interfere trans dominantly with multiple activities of wild-type large T antigen.
Simian virus 40 (SV40) large T antigen is a multifunctional,
708-amino-acid phosphoprotein. T antigen is located primar-
ily in the nucleus, but a small amount is found in the
cytoplasm and at the cell surface. T antigen plays essential
roles during both lytic and transforming infections by SV40.
It binds specifically to sequences at the SV40 origin of
replication and nonspecifically to cellular DNA. Large T
antigen also possesses ATPase and helicase activities (52,
64).
Sequences within T antigen sufficient for binding to the
SV40 origin of DNA replication have been localized to the
region between amino acids 131 and 259 (3, 54); however,
mutations affecting the putative metal-binding finger region
(amino acids 302 to 320) show altered DNA binding, suggest-
ing that this region might interact with and regulate the DNA
binding domain (3). Genetic and immunological studies
indicate that the ATPase and helicase activities of large T are
contained within the region between amino acids 350 and 600
(10, 14). The C terminus of T antigen constitutes a separate
functional domain involved in providing adenovirus helper
function and a host range function (hr/hf function) (12). hrlhf
mutants replicate to the same level as wild-type SV40 in all
monkey kidney cell lines examined but produce progeny
virus inefficiently in CV-1 monkey kidney cells (40, 66, 67).
SV40 T antigen is phosphorylated (59), glycosylated (23),
ADP ribosylated (22), acylated (27), and adenylylated (7).
Phosphorylation sites are clustered in two regions. Several
are located between Ser-106 and Thr-124, while others are
located near the C terminus, from Ser-639 to Thr-701 (42,
* Corresponding author.
68). T antigen exists as monomer and oligomerizes into
dimeric, tetrameric, and higher-order forms (35). A cell
cycle-related protein, p53, is physically associated with and
metabolically stabilized by T antigen in both permissive and
nonpermissive cells (28). T antigen is also associated with
transcription factor AP-2 (33) and DNA polymerase a (47).
The binding of DNA polymerase a to T antigen can be
blocked in vitro by p53. This suggests that DNA polymerase
a and p53 bind to the same or physically adjacent sites on
large T antigen (18). Recently, T antigen has been found to
form a complex with the retinoblastoma susceptibility gene
product Rb (15). T-antigen sequences located between
amino acids 105 and 114 are important for complex forma-
tion between T and Rb (15). Whether other T-antigen se-
quences are also important for Rb binding has not been
determined.
Large T antigen performs multiple functions during lytic
and transforming infections by SV40. The DNA binding and
ATPase-helicase activities of T are required for viral DNA
replication (47, 64, 69). For T antigen to be active in DNA
replication, these activities must be located within a single
T-antigen monomer (14). T antigen autoregulates synthesis
of its own mRNA (2, 60). At low levels, T stimulates
transcription of SV40 early mRNA (25), while at higher
concentrations, T acts to repress early mRNA synthesis (2).
T antigen can transactivate transcription from a number of
viral and cellular promoters, including the SV40 late (8, 24),
adenovirus E2 (29), Rous sarcoma virus long terminal repeat
(1), and rRNA promoters (48). T antigen induces host cell
DNA synthesis (17, 49). It also plays central roles in immor-
talization of primary cells (61, 62) and in the malignant
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transformation of established cell lines (26, 58). Mutants
with defects in DNA binding, ATPase-helicase, or hr/hf
function retain the ability to immortalize cells at the same
frequency as wild-type SV40, indicating that none of these
activities of T antigen are required for immortalization (14,
62).
Mutational analysis has played a central role in assigning
functional activities to specific domains of T antigen. To
study further the organization, interaction, and activities of
the various domains of T antigen, we inserted a 12-base-pair
(bp) synthetic oligonucleotide linker into multiple sites
within the SV40 early region. Here we present the initial
characterization of these mutants. Ten were nonviable,
belonged to the A complementation group, and were defec-
tive in viral DNA replication. Several of these mutants
interfered with the functions of wild-type T antigen. Plaque
formation was delayed in cells coinfected by a capsid protein
mutant and some linker insertion mutants. In addition,
replication of viral DNA was reduced up to 20-fold in Cos-1
cells transfected by some mutants; these cells produce
wild-type large T antigen constitutively (19). Not all mutants
that showed delayed complementation showed reduced rep-
lication in Cos-1 cells. Mutations which resulted in trans-
dominant interference were located at many sites.
MATERIALS AND METHODS
Cells, tissue culture, and plasmid DNAs. CV-1, CV-lp, and
BSC-1 cells are permanent lines of African green monkey
kidney cells. Cos-1 cells are a derivative of CV-1 cells
transformed with an origin-defective SV-40 and produce
SV40 large T antigen constitutively. Cells were cultured in
Dulbecco modified Eagle medium (DMEM) containing 10%
fetal calf serum (FCS), unless specified otherwise. Our
wild-type strain of SV40 was the small-plaque strain orig-
inally characterized by Takemoto et al. (56). Standard tech-
niques were used for bacterial growth and transfection (31),
minilysate DNA preparation and analysis (5), and large-scale
plasmid purification by CsCl-ethidium bromide buoyant den-
sity centrifugation.
Construction of mutants. A plasmid containing the com-
plete SV40 genome inserted into the EcoRI site of pUC18
(pCC2Pa) was used for mutant constructions. The early
region of SV40 from the KpnI site (nucleotide 294) (65) to the
BamHI site (nucleotide 2533) was isolated from pCC2Pa and
subcloned between the BamHI and KpnI sites in the poly-
linker of pUC18. This plasmid DNA was digested with either
AluI, DraI, or SspI, in the presence of ethidium bromide (33
,ug/ml) for 1 to 2 h, to limit cleavage to once per molecule
(45). After digestion, the DNA was fractionated by electro-
phoresis in a 0.7% agarose gel in TBE buffer (89 mM Tris
hydroxide, 89 mM boric acid, 2.5 mM EDTA [pH 8.3]). Unit
length, linear DNA was isolated from the gel and purified by
extraction with phenol and chloroform, followed by ethanol
precipitation. These linear molecules were then ligated, by
using T4 DNA ligase, with a large molar excess of a 12-bp
non-phosphorylated synthetic oligonucleotide linker, d(TCG
CGATCGCGA), purchased from New England BioLabs.
This linker contains two NruI sites and a single PvuI site.
After ligation, the DNA was heated at 90°C for 30 s, cooled
at room temperature for 30 min, and transformed into
Escherichia coli HB101. The sites of linker insertion were
determined by restriction endonuclease digestion of minily-
sate DNA preparations, which indicated which AluI, DraI,
or SspI site was missing and where NruI and PvuI sites had
been inserted. The mutant SV40 early regions, as KpnI to
BamHI fragments, were then isolated from 0.7% agarose
gels and ligated with the BamHI to KpnI fragment of
pCC2Pa, which contains the remainder of the SV40 genome
and pUC18. These mutants were assigned SV40 mutant
numbers in the 2800 series.
Plaque and complementation assays. Viral DNAs were
separated from pUC18 sequences by digestion with EcoRI
and circularized by ligation at low concentration (5 mg/ml)
with T4 DNA ligase. Agarose gel electrophoresis was used
to monitor digestion and ligation. CV-1 cells in 60-mm plates
were incubated for 45 min with 0.3 ml of DNA solution
containing 500 mg of DEAE-dextran per ml in Tris-buffered
saline (TS; 25 mM Tris chloride [pH 7.5], 137 mM NaCl, 5
mM KCl, 0.6 mM Na2HPO4, 0.05 mM MgCl2, 0.7 mM
CaCl2) and various dilutions of viral DNAs. Cells were then
washed twice with TS and were overlaid with 3 ml ofDMEM
containing 4% FCS and 1% Bacto-Agar (Difco Laborato-
ries). Plates were overlaid 3 to 4 days later and stained 6 to
7 days after transfection with 0.01% neutral red. The plaques
were counted every day after staining for about 2 weeks.
Complementation assays were performed in the same
manner, except cells were transfected with a mixture of two
mutant DNAs, as described previously (66). Each 60-mm
plate received 0.1 mg of helper DNA and 0.1, 0.01, or 0.001
mg of mutant DNA.
Viral DNA replication. Mutant SV40 DNAs were sepa-
rated from pUC18 sequences, circularized as described
above, and introduced into CV-lp or COS-1 cells in 60-mm
plates by using DEAE-dextran, as described above. After 45
min at 37°C, cells were washed twice with TS and then fed
with 5 ml of DMEM containing 2% FCS-100 mM chloro-
quine diphosphate (Sigma Chemical Co., St. Louis, Mo.).
After 6 h, chloroquine-containing medium was replaced with
DMEM containing 2% FCS. Viral DNAs were harvested 0,
1, 3, and 5 days after transfection as described previously
(40, 66, 67). The DNAs were digested with MboI and
fractionated on a 1.5% agarose gel. Input DNAs had been
isolated from dam' bacteria and were therefore methylated
(GAmTC) and resistant to MboI digestion, while DNA which
had replicated in mammalian cells was not methylated at
GATC and was therefore sensitive to MboI digestion. After
electrophoresis, DNAs were transferred to Nytran nylon
(Schleicher & Schuell, Inc., Keene, N.H.), and hybridized
under standard conditions with 32P-labeled, nick-translated
pCC2Pa DNA. After hybridization and washing, the nylon
blot was exposed to Kodak XAR-5 film for autoradiography.
Plasmid p6-1 (a gift from J. Alwine) contains the complete
genome of an SV40 mutant lacking 6 bp at the BglI site in the
origin of replication (21, 24). In some experiments, CV-1,
HeLa, or 293 cells were cotransfected with insertion mutant
and p6-1 DNAs by the calcium phosphate method (70). Cells
were incubated in the presence of the calcium phosphate
precipitate for 18 h. Cells received 0.5 mg of each recircu-
larized viral DNA and 5 mg of salmon sperm DNA (Sigma)
as a carrier. Cultures were harvested and low-molecular-
weight DNAs were isolated 1, 2, 3, and 5 days after
transfection, as described above. These DNAs were di-
gested with MboI and EcoRI and analyzed as described
above.
Pulse-chase labeling and immunoprecipitation of T anti-
gens. BALB/c 3T3 cell lines expressing mutant or wild-type
SV40 large T antigens were prepared by cotransfecting cells
with mutant or wild-type SV40 DNAs and pSV2neo (51).
Colonies were isolated after selection in DMEM containing
10% FCS and 500 mg of G418 per ml, screened for the
production of SV40 large T antigen by immunofluorescence,
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and maintained in DMEM containing 10% FCS and 250 mg
of G418 per ml. The production of large T antigen in the cell
lines was confirmed by Western blotting (immunoblotting)
analysis.
To examine the stabilities of mutant T antigens, 2 x 105
Mutant ion Fraes Wildtype




2801 5150 5 3 4 6
Val Phe Arg Asp rg Glu Asn
34 35 36
2803 5060 35 2 AyrgAEL Lys14~~~~~~~3 36bS
Tyr Phe ^ Ap Gh Lys
167 168 169
2815 4316 168 31 Lys A Ala
Lys Val Ala Ile Ala Thr Ala
218 219 220
2817 4162 219 2 Phe Ser Phe3 218 220
Phe Ser Arg ALp Arg Asp Phe
302 303 304
2807 3910 303 3 e Lys
Cys Phe Arg At Ag Asp Lys
345 346 347
2819 3782 346 -1 LeuA Lys
Leu Val Ala ne Ala Thr Lys
408 409 420
2809 3592 409 PheL¶Lys3 408 409
Phe Phe Arg A rAg Asp Lys
424 425
2811 3546 424 0 PheLys3 424 425
Phe Ser Arg Ser Arg Lys
460 461
2821 3438 460 0 GluLeu3 460 461
Glu Ser Ag Ser Arg Leu
463 464 465
2823 3428 464 ~ Val aaIle3 463 4t65
Val Val Ala I Ala Thr Ile
519 520 521
2827 3259 520 Gln Ile Phe3 519 521
Gln Ile Avg ArpgGlu Phe
519 520 521
2828 3259 520 2 Glni 521
Gln Ile A Glu Phe
173 174
2829 4643 173 0 LysLy Stop
(sd 3 173 174smalt) Lys Ser Arg Sfr Avg Leu Stop
cells were seeded onto 60-mm plates the day before labeling.
The cells were washed twice with TS and incubated for 1 h
at 37°C in 2 ml ofDMEM lacking methionine and containing
2% dialyzed FCS. The medium was removed, and the cells
were labeled for 2 h with 100 iCi of [35S]methionine (Du-
pont, NEN Research Products, Boston, Mass.) in 0.7 ml of
DMEM lacking methionine and containing 2% dialyzed
FCS. Cells were washed twice with TS and incubated in
DMEM containing 10% FCS. Cultures were harvested after
chase periods of 0, 5, and 17 h and were lysed with 0.5 ml of
EBC buffer (50 mM Tris chloride [pH 8.0], 100 mM NaCl,
0.5% Nonidet P-40, 0.1 U of aprotinin per ml [15]) for 20 min
at 4°C. The cellular debris were removed by centrifugation
for 15 min at 4°C in a microcentrifuge. Extracts from
identical numbers of cells were mixed with 10 Rl of a mixture
of mouse ascites fluids containing monoclonal antibodies
PAb901 and PAb9O2 (a gift from S. Tevethia and J. Te-
vethia). These antibodies recognize denaturation-resistant
determinants located at the carboxy and amino termini of
large T antigen, respectively (J. Tevethia and S. Tevethia,
personal communication). Mixtures were rocked for 1 h at
4°C. Protein A-Sepharose beads (20 ,ul; Sigma) (1:1 mixture
in Tris-buffered saline-bovine serum albumin [15]) were
added to the mixture, and rocking was continued for 30 min
at 4°C. The Sepharose beads were pelleted by centrifugation
and washed three times with 1 ml EBC buffer at 4°C.
Immunoprecipitated proteins were released by heating in
sample buffer for 15 min at 70°C and analyzed by electro-
phoresis in sodium dodecyl sulfate-7.5% polyacrylamide
gels, followed by fluorography. The relative intensities of
T-antigen bands were determined by densitometric scan-
ning. Serial dilutions of "S-labeled proteins were electro-
phoresed on a parallel gel and analyzed in the same way.
This indicated that the densitometric readings reflected
accurately the amount of 3"S-labeled large T antigen.
RESULTS
Construction of linker insertion mutants. A set of mutants
was prepared by insertion of a 12-bp oligonucleotide linker,
d(TCGCGATCGCGA), into DraI, SspI, and AluI sites
within the SV40 early region. All three enzymes cleave
multiple times in the large T-antigen-coding region and leave
blunt ends on cleaved DNA. Digestion of SV40 DNA with
these enzymes was performed in the presence of ethidium
bromide so that a large fraction of the DNA was full-length
linear molecules. Full-length, linear DNA was isolated from
an agarose gel and ligated with the linker. The linker
contains two NruI sites and a single PvuI site. Mutants were
analyzed by restriction endonuclease digestion. All mutants
were assigned numbers in the 2800 series; for clarity in this
paper, mutants are also referred to by the position within the
T antigen where additional amino acids were inserted. For
example, the mutant inA2803 contains an insertion of 4
amino acids within codon 35; we refer to this mutant as
inA2803(aa35). These linker insertion mutants encode large
FIG. 1. Linker insertion mutants of SV40. Mutants were pre-
pared as described in Materials and Methods. The T antigen codon
interrupted by or immediately upstream of the inserted linker is
listed. The frame of insertion refers to whether the linker was
inserted between 2 codons (0/3), after the first nucleotide of the
disrupted codon (1/3), or after the second nucleotide of the disrupted
codon (2/3). The amino acid sequences of wild-type and insertion
mutant T antigens, at the site of insertion, are shown. All insertions
maintain the normal reading frames on both sides of the insertion.
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T antigens which differ from the wild type by the addition of
four amino acids at the site of the linker insertion (Fig. 1).
The sequence of amino acids inserted depends on the
reading frame of the insertion. Mutant inA2828(aa520) was
derived from inA2827(aa520) by digestion to completion with
NruI followed by ligation. This excised 6 bp from the DNA,
resulting in a mutant which encodes a large T antigen
containing 2 amino acids inserted at the position of amino
acid 520.
Biological properties of the mutants. The effects of the
mutations on the SV40 lytic infection cycle were examined
by plaque assay. Circularized viral DNAs were transfected
into CV-lp and BSC-1 cells. Mutants inA2801(aa5) and
inA2829(small t) were viable and formed plaques of the same
size and with the same efficiency as wild-type SV40 in CV-lp
cells at 33, 37, and 41°C and in BSC-1 cells at 37°C. The
mutation in inA2829(small t) is in the region encoding the
carboxy terminus of small t antigen; its viability is consistent
with the previous observation that mutants affecting only
small t antigen have little effect on lytic infection by SV40.
Mutant inA2801(aa5) has a linker inserted at amino acid
codon 5, suggesting that a mutation near the amino terminus
of T antigen does not have major effects on the functions of
T antigen required during the lytic cycle. None of the other
mutants formed plaques in CV-lp and BSC-1 cells.
The SV40 large T antigen plays an essential role in
initiation of viral DNA replication (57). To see whether any
of these new nonviable mutants were positive for viral DNA
replication, mutant DNAs were transfected into CV-1 cells.
Cells were harvested 0, 1, 2, and 3 days after transfection,
and viral DNA was isolated. Sensitivity ofDNA produced in
eucaryotic cells to digestion by MboI was used to distinguish
the progeny DNA from input DNA. After MboI digestion,
the DNAs were analyzed by Southern blotting. No viral
DNA replication was detected in the cells transfected by any
of the nonviable mutants.
Genetic complementation analysis. The ability of the non-
viable insertion mutants to complement early and late gene
mutants was tested by cotransfecting CV-lp cells with
insertion mutant DNA and DNA from early- and late-gene
mutants. Mutant dIA1209 (12) lacks 329 bp (nucleotides 4862
to 5191), including the normal early mRNA cap site, the
entire first exon of the large T-antigen-coding region, and the
5' splice site of the large T-antigen intron. It encodes no T
antigen but can provide capsid proteins. As expected, none
of the nonviable insertion mutants was able to complement
dlA1209 (Table 1). Mutant dlBC865 contains a small deletion
at the SV40 EcoRI site (nucleotide 1782) and produces a
short amino-terminal fragment of VP1 and a wild type T
antigen (9). All early gene mutants were expected to com-
plement this mutant. All the nonviable insertion mutants did
indeed complement dIBC865. However, the time of appear-
ance and the numbers of plaques formed varied from mutant
to mutant. In control plates which received 50 ng of both
dlA1209 and dlBC865 DNA, about 50 plaques appeared on
each 60-mm plate 6 to 7 days after transfection, and the
number reached a maximum of about 200 plaques on day 10
or 11. Mutants inA2815(aal68), inA2817(aa219), inA2807
(aa303), inA2809(aa409), inA2811(aa424), and inA2823
(aa464) complemented dlBC865 as well as dIA1209 (Table 1).
Mutants inA2803(aa35), inA2819(aa346), inA2821(aa460),
and inA2827(aa520) showed delayed complementation with
dlBC865. In plates transfected with inA2803(aa35) and
dlBC865, plaques appeared 3 to 4 days later and grew more
slowly than the control (dlBC865 and dlA1209). However,
the specific infectivities (in PFU per milligram) of these
TABLE 1. Mutant DNA replication in COS-1 cells and
complementation analysis
Complementation' Viral DNACodon replication in
Mutant of COS-1 cells
insertion dIA1209 dlBC865 dlA2475 (% ofd1A12O9dIBC865 d1A2475 dlA1209)b
2801C 5 NT NT NT 210
2803 35 - Delayed Delayed 78
2815 168 - + + 99
2817 219 - + Delayed 50
2807 303 - + + 119
2819 346 - Delayed - 20
2809 409 - + + 125
2811 424 - + + 107
2821 460 - Delayed - 20
2823 464 - + Delayed 37
2827 520 - Delayed - 9
2828 520 NT NT NT 10
WTd NT NT NT 314
A1209 - + - 100
BC865 + + NT
A2475 - + - NT
a Complementation assays are described in Materials and Methods. +,
Plaques appeared at the same time as in the control (d1BC865 or dIA1209), that
is, 6 to 7 days after transfection; Delayed, plaques appeared more than 10 days
after transfection. NT, Not tested; -, no plaques appeared.
b The numbers represent the relative levels of DNA replication in Cos-1
cells (level in dlA1209 = 100) averaged from samples isolated 3 and 5 days
after transfection. The values were derived from densitometric scanning of
comparable bands on Southern blot autoradiographs from one experiment.
The experiments were repeated, and similar levels of DNA replication were
observed.
c inA2801(aa5) was viable and was not tested for complementation.
d WT, Wild type.
mutants were similar to that of dlA1209. Complementa-
tion between dlBC865 and either inA2819(aa346) or
inA2821(aa460) was also delayed by 3 to 4 days. Fewer
plaques (20 to 50% of the total in the control) were formed,
but the plaques formed were normal in size and rate of
enlargement. In the case of inA2827(aaS20), the plaques
appeared at least 7 days later than on control plates. The
specific infectivity of inA2827(aa520) DNA was 10 to 20% of
that of dlA1209. We do not know whether more plaques
would have appeared after further incubation because these
cells died after 20 days of incubation, even without SV40
infection. Complementation between dlBC865 and inA2817
(aa219) or inA2823(aa464) was delayed by 1 to 2 days in
some experiments and was normal in other experiments.
The C-terminal 80 amino acids of SV40 large T antigen
provide the hr/hf function (13, 66, 67). Mutants whose T
antigens lack this domain fail to help human adenoviruses to
grow in monkey cells and are unable to form plaques on
CV-lp cells. These mutants produce plaques on BSC-1 cells
and produce normal progeny yields in Vero cells (13). A
well-characterized members of this class, dlA2475, produces
a T antigen lacking the C-terminal 26 amino acids (13). We
reported previously that this mutant is able to complement
intracistronically other group A mutants that produce T
antigens containing an intact C terminus (66). Formation of
plaques by complementation (Table 1) between dlA2475 and
inA2803(aa35), inA2817(aa219), or inA2823(aa464) was de-
layed by 3 to 5 days. Mutants inA2819(aa346), inA2821
(aa460), and inA2827(aa520) did not complement dlA2475.
These results indicate that some of the insertion mutant T
antigens, even though they contain normal C termini, were
unable to complement an hrlhf mutant. This could reflect
J. VIROL.
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FIG. 2. Mutant SV40 DNA replication in Cos-1 cells. Cos-1 cells were transfected with mutant DNAs. Progeny DNA was harvested 0,
1, 3, and 5 days later, digested with MboI, and analyzed by electrophoresis in 1.5% agarose gels. After electrophoresis, a Southern blot was
prepared (50) and autoradiographed. Lanes M, Plasmid pCC2Pa digested with Hinfl. Equal amounts of these markers were added on both
sides of each gel to monitor the evenness of transfer of DNA to the nylon membrane and of hybridization with the radiolabeled probe. The
lanes marked viral DNAIMboI contained MboI-digested SV40 DNA isolated from infected cells. The presence of an MboI site within the
linker caused different mutants to have fragments of different sizes. WT, Wild type.
either their inability to provide the hr/hf function or, more
likely, their interference with replication activities of
dlA2475 T antigen.
Insertion mutant viral DNA replication in Cos-l cells. The
interference of mutant T antigens with wild-type (or
dlA2475) T antigen could occur during viral DNA replication
or at some other steps during the lytic infection cycle. To
examine the interference further, viral DNA replication was
analyzed in Cos-1 cells transfected by various insertion
mutants. In Cos-1 cells, the large T encoded by the inte-
grated SV40 genome permits replication of introduced DNA
molecules containing a functional SV40 origin of DNA
replication. Viral DNAs were isolated 0, 1, 3, and 5 days
after transfection. MboI digestion was again used to distin-
guish the input DNA from progeny DNA in Cos-1 cells (Fig.
2). Mutant dlA1209 served as a positive control; because
dlA1209 encodes no T antigen, the replication of dIA1209
DNA reflected the activity of the endogeneous large T
antigen encoded by the integrated SV40 genome. Wild-type
SV40 replicated to a higher level in Cos-1 cells than dlA1209;
this probably reflects the contribution to replication of both
the endogenous T antigen and the wild-type T encoded by
transfected SV40 DNA (Fig. 2D). The replication of
inA2817(aa219) (Fig. 2B), inA2819(aa346) (Fig. 2C),
inA2821(aa460) (Fig. 2C), inA2823(aa464) (Fig. 2C), and
inA2827(aa520) (Fig. 2D) DNAs was significantly reduced
(50 to 95%) compared with that of dlA1209. Mutant
inA2828(aa520) (Fig. 2D), which contains a 6-bp insertion at
the same site as the 12-bp insertion of inA2827(aa520),
replicated to the same reduced extent as inA2827(aa520),
which replicated 5 to 10% as well as dlA1209. All these
mutants showed reduced complementation with either a
late-gene mutant (d1BC865), an hrlhf mutant (dlA2475) or
both. The data in Fig. 2 demonstrate that some of the
insertion mutant T antigens interfered with the replication
functions of wild-type T antigen.
The replication of inA2803(aa35) (Fig. 2A) in Cos-1 cells
was slightly reduced compared to that of dlA1209. Interest-
ingly, this mutant also showed delayed complementation
with dlBC865 and dlA2475. In contrast, mutants inA2817
(aa219) (Fig. 2B) and inA2823(aa464) (Fig. 2C) replicated
much less well in Cos-1 cells than mutant inA2803(aa35),
even though they complemented dlBC865 normally. This
could indicate that inA2803(aa35) interfered with functions
of wild-type T antigen distinct from viral DNA replication.
Finally, some of the insertion mutants [inA2807(aa303) (Fig.
2A), inA2809(aa409) (Fig. 2A), inA2811(aa424) (Fig. 2B),
and inA2815(aal68) (Fig. 2B)] replicated as well as dlA1209.
Interactions between wild-type and mutant T antigens in
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FIG. 3. Viral DNA replication in cotransfected CV-lp cells.
CV-lp cells were cotransfected with plasmid p6-1 and inA2827
(aa520) or d1A1209 DNAs. Other cultures were transfected with
wild-type SV40 DNA. Progeny DNA was harvested 1, 2, 3, and 5
days after transfection, digested with MboI and EcoRI, and ana-
lyzed by electrophoresis in a 1.5% agarose gel. After electrophore-
sis, a Southern blot was prepared and autoradiographed. Lane M,
Plasmid pCC2Pa digested with Hinfl. Equal amounts of these
markers were added on each side of the gel to monitor the evenness
of transfer ofDNA to the nylon membrane and of hybridization with
the radiolabeled probe. Transfer was even; only the left marker is
shown. Lanes 2 to 5, inA2827(aa520) and p6-1 cotransfection; lanes
6 to 9, d1A1209 and p6-1 cotransfection; lanes 10 to 13, wild-type
SV40 transfection.
interfere with wild-type T antigen activities was also exam-
ined in cells cotransfected with inA2827(aa520) and a plas-
mid expressing wild-type T antigen. We used plasmid p6-1,
an origin-defective plasmid expressing wild-type T antigen.
The absence of a functional origin of replication prevented
replication from occurring in cells which received only p6-1
(data not shown). Viral DNA replication could not occur in
cells which received only mutant DNA, since all mutants
examined in this experiment were replication defective.
Only cotransfected cells contained both a functional origin of
replication (provided on the plasmid expressing mutant T
antigen) and a replication-competent T antigen (provided on
plasmid p6-1).
Much less viral DNA replication occurred in CV-1 cells
(Fig. 3) cotransfected by inA2827(aa520) and p6-1 (lanes 2 to
5) than in cells transfected by wild-type SV40 (lanes 10 to 13)
or cotransfected by dlA1209 and p6-1 (lanes 6 to 9). We
estimate that inA2827(aa520) replicated to only 5 to 10% of
the level of the control plasmid, dlA1209. We observed a
similar interference by inA2827(aa520) in cotransfected
HeLa and 293 cells (data not shown).
Stabilities of mutant T antigens. The inability of a mutant T
antigen to carry out some functions of T could be caused
either by absence of the protein, due to instability, or to a
functional defect in the mutant polypeptide. Analogously,
interference with wild-type T may be a common effect of a
stable mutant T antigen; the lack of interference by some of
the insertion mutant T antigens could reflect their instability.
To examine this possibility, cell lines expressing mutant T




FIG. 4. Analysis of the stabilities of mutant T antigens (T Ag).
BALB/c 3T3 cells (2 x 105) expressing the mutant T antigens were
seeded onto 60-mm dishes the day before radiolabeling. Cells were
pulse-labelled for 2 h with [35S]methionine, and then either lysed
immediately or chased in complete medium for 5 or 17 h (as
indicated at the top of the figure) before lysis. Portions of cell lysates
from identical numbers of cells were immunoprecipitated with a
mixture of monoclonal antibodies PAb901 and PAb902, analyzed by
electrophoresis on a sodium dodecyl sulfate-7.5% polyacrylamide
gel, and fluorographed. WT, Wild type.
with pSV2neo and either wild-type or mutant SV40 DNAs,
followed by selection for resistance to G418. The stabilities
of the mutant T antigens were measured by pulse-labeling
cells for 2 h with [35S]methionine, followed by incubation in
complete medium for 0, 5, or 17 h. The T antigens were
immunoprecipitated with anti-T antigen monoclonal antibod-
ies PAb901 and PAb9O2, which recognize epitopes near the
C terminus and N terminus of large T antigen, respectively
(J. Tevethia and S. Tevethia, personal communication).
Some examples of the fluorograms obtained are shown in
Fig. 4. The fraction of labeled T antigen remaining after 5-
and 17-h chase periods was determined by densitometric
scanning of fluorograms; these data are presented in Table 2.
All of the mutant T antigens except inA2807(aa303) were as
stable as wild-type T. Mutant inA2807(aa303) produces a T
antigen containing additional amino acids at amino acid 303.
This T antigen was very unstable since labeled T antigen was
not be detected after a 5-h chase. For the wild type and most
of the other mutants, 30 to 50% of the labeled T antigen
remained after the 5-h chase. The fraction of T antigen
remaining after the 17-h chase ranged from 50% [inA2819
(aa346)] to 170% [inA2827(aa520)] of the amount of wild-type
T antigen remaining after 17 h. These findings indicate that
the behavior of most mutant T antigens in genetic comple-
mentation tests and the replication patterns of most mutants
in Cos-1 cells reflect the properties of the mutant T antigens,
rather than their instability.
We were unable to obtain cell lines which expressed
inA2803(aa35) T antigen. The transfection protocol used a
10:1 molar ratio of insertion mutant DNA to pSV2neo.
Under those conditions, most G418' clones isolated were
expected to contain the insertion mutant genome. Fewer
G418r clones were obtained with inA2803(aa35); of the 16
clones examined, all were negative for expression of
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TABLE 2. Stabilities of large T antigens encoded by SV40
insertion mutantsa
Fraction of T antigen remaining
Mutant no. after chase













WT-super Tb 0.47 0.10
a The data are from densitometric scannings of fluorograms like the one
shown in Fig. 4. The numbers were normalized to the amount of T antigen
present after the 2-h pulse-labeling.
b There were two T antigen bands immunoprecipitated from BALB/c 3T3
cells transformed by wild-type (WT) SV40 (Fig. 4). One migrates at the
position expected for wildtype SV40 large T antigen. A larger species, super
T, has been described previously (8a) and is often found in SV40-transformed
cells.
inA2803 T antigen. This suggests that expression of
inA2803(aa35) T antigen is deleterious or lethal.
DISCUSSION
In this paper, we have described the preparation and initial
characterization of a set of mutants which contain a 12-bp
oligonucleotide linker inserted into restriction endonuclease
cleavage sites located at positions within the SV40 early
region. The ability of these mutants to produce plaques was
tested in CV-lp cells at three different temperatures and in
BSC-1 cells at 37°C. The only mutant affecting large T
antigen which was able to produce plaques under any of the
conditions tested was inA2801(aa5), which has a linker
inserted at amino acid codon 5 of both small and large T
antigens. Since small t is not required for the SV40 lytic
cycle in monkey kidney cell lines, our studies do not indicate
whether this alteration affects any of the properties of small
t. The finding that alterations can be made near the amino
terminus of large T without affecting viability is interesting.
No other SV40 mutants with lesions in this region have been
described. Mutants with insertions or deletions located
slightly further from the N terminus have been prepared, are
nonviable, and belong to the A complementation group.
These include inA2803(aa35), described in these studies, and
dlA1135, lacking amino acids 17 to 27 (11, 39). Mutant
dlA1135(aa35) is defective for binding to the SV40 origin of
DNA replication and for ATPase activity. The adenovirus-
SV40 hybrid T antigen, D2, is competent for SV40 DNA
replication, even though it lacks the amino-terminal 114
amino acids of large T and has, in their place, 104 amino
acids encoded by adenovirus DNA sequences (4, 63, 64).
These data are consistent with the amino-terminal portion of
large T playing a structural role in the overall conformation
of the protein or with its being needed for other activities of
T antigen or both. The changes in the protein caused by the
insertion at codon 5 did not alter the ability of the protein to
induce DNA replication. In preliminary experiments, we
have found that the T antigen encoded by inA2801(aa5) was
less active than wild-type T antigen in transactivation of the
SV40 late promoter and in transformation of mouse 1OT1/2
cells and rat REF52 cells (Zhu and Cole, manuscript in
preparation).
Six of the mutants we described, with the linker inserted at
codons 35, 219, 346, 460, 464, and 520, had reduced abilities
to complement late-gene mutant dlBC865, hrlhf mutant
dlA2475, or both. These defects in genetic complementation
could reflect additional mutations in the mutant genomes,
affecting the SV40 origin of replication, VP1 (the BC gene
product), or the hr/hf region (the C terminus of T antigen).
However, the inability of some insertion mutants to comple-
ment either a BC mutant or an hrlhf mutant would require
multiple additional lesions, making this possibility unlikely.
The T antigens encoded by dlBC865 and dlA2475 are both
competent for viral DNA replication; the insertion mutants
provide capsid protein and hr/hf activity. Our results suggest
that the complementation patterns reflect the activities of the
mutant large T antigens. We believe that these T antigens
interfere directly with wild-type large T functions required
during the lytic cycle.
To determine whether the mutant T antigens could inhibit
viral DNA replication mediated by wild-type T, we analyzed
viral DNA replication after transfection of mutant genomes
into Cos-1 cells. All of the mutants which showed delayed
complementation showed reduced levels of replication. This
reduction could be caused by defective origins of replication.
We have replaced the origin regions of two of these insertion
mutants without affecting their ability to interfere. This
indicates that trans-dominant interference is a property of
the mutant T antigens.
The degree of interference with viral DNA replication in
Cos-1 cells varied from mutant to mutant. inA2803(aa35)
replicated slightly but reproducibly to a level about 25%
below that of the control DNA, dlA1209, which produced no
T antigen. DNA replication of mutant inA2817(aa219) was
inhibited by more than 50% and inA2827(aa520) and
inA2828(aa520) by more than 90% (Fig. 2, Table 1). Similar
levels of interference with viral DNA replication were seen
in CV-1, HeLa, or 293 cells cotransfected with inA2827
(aa520) and an origin-defective plasmid encoding wild-type T
antigen (Fig. 3).
It is interesting that inA2803(aa35) replicated better than
inA2817(aa219) or inA2823(aa464), even though inA2817
(aa219) and inA2823(aa464) complemented dlBC865 more
efficiently than inA2803(aa35). This raises the possibility that
there are multiple mechanisms by which mutant T antigens
can interfere with wild-type T functions. We are currently
conducting experiments to determine whether activities ofT
other than viral DNA replication are susceptible to trans-
dominant interference by mutant T antigens.
We also noted that several of the mutant T antigens did not
interfere with the replication activity of wild-type T antigen.
The possibility that this reflects instability of these mutant T
antigens was examined (Fig. 4, Table 2). Only one of the T
antigens encoded by noninterfering mutants [inA2807
(aa303)] was unstable. Loeber et al. (30) described several
point mutations affecting the region from amino acid 302 to
320 and suggested from their results that this region may be
involved in the overall structural framework of the protein.
Mutant T antigens that are stable and do not interfere
might not oligomerize, either with themselves or with wild-
type T. Alternatively, these T antigens might be unable to
form complexes with host DNA replication proteins. Inter-
ference might be possible only ifT antigen contained specific
VOL. 63, 1989
4784 ZHU AND COLE
posttranslational modifications, and some mutant T antigens
might show a pattern of modifications different from those of
wild-type T.
Other T-antigen mutants which show trans-dominant in-
terference have been described. Mutants 5061 and 5062 (16)
produce T antigens containing amino acid insertions or
substitutions in the vicinity of amino acid 430, in the domain
involved in nucleotide binding and ATPase-helicase activity.
Some of the mutants examined in our experiments affect
sites relatively close to the position of the mutations of 5061
and 5062; others affect sites quite distant from them. Mu-
tants of polyomavirus showing trans-dominant interference
with polyomavirus DNA replication have also been reported
(37) and have lesions in the ATPase region of polyomavirus
large T antigen.
The ability of some purified SV40 mutant T antigens to
interfere with viral DNA replication in vitro has also been
reported. Mutants C6-2, T22, C8A, C2, and Cll, with amino
acid changes at positions 153, 203, 224, 516, and 523 or 549,
respectively, were able to inhibit viral DNA replication in a
concentration-dependent manner. Addition of a threefold
molar excess of the mutant T antigen resulted in a 75 to 90%
reduction in the amount of radiolabeled substrate incorpo-
rated into SV40 DNA. In contrast to our studies and those of
Farber et al. (16), the mutant T antigens described by
Stillman et al. (53) did not interfere with viral DNA replica-
tion when monkey cells producing the mutant T antigens
were infected with wild-type SV40 (20).
There are multiple ways in which a mutant T antigen could
interfere with wild-type DNA replication. It could bind to
and block origins of DNA replication, preventing wild-type
T antigen from using them. Alternatively, the mutant T
antigen could oligomerize with wild-type T, forming mixed
oligomers inactive in viral DNA replication. We do not know
whether all of the monomers in an oligomer must be active
for the oligomer to participate in viral DNA replication. The
monomeric form and possibly the dimeric form (5S-7S) of T
antigen are less phosphorylated (6, 36, 43, 55) and more
active in DNA binding than higher-order oligomers (6, 41).
Phosphorylation of T antigen down-regulates the DNA rep-
lication mediated by T antigen (34, 46). Finally, T could
interfere by binding to and sequestering some host compo-
nent essential for viral DNA replication. T is known to
interact with host DNA polymerase a (18, 47) and might
interact with other cellular DNA replication proteins.
trans-Dominant interference in procaryotes, where the
formation of oligomers is essential for regulation to occur,
has been described. The ability of mutant polypeptides to
interfere with wild-type activity through formation of mixed
oligomers has been described in the lac repressor system
(32) and in the case of recA (38, 44, 71, 72). Additional
experiments will be required to determine whether there are
multiple mechanisms for trans-dominant interference by
SV40 T antigen and how these mutant T antigens interfere.
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